← Back to patent-cliff list
Tramadol Hydrochloride/Etoricoxib
Tier C — Watch / tradeTramadol Hydrochloride/Etoricoxib
Laboratorios Silanes Sa De Cv
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
-
Type
Targets：MOR1, COX-2
Indications (approved)：Low back pain, 急性疼痛, Postoperative pain
Regional status
US
-
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Tramadol Hydrochloride/Etoricoxib?
Approved indications include: Low back pain, 急性疼痛, Postoperative pain.
When does the Tramadol Hydrochloride/Etoricoxib patent expire?
No public expiry year is available for Tramadol Hydrochloride/Etoricoxib yet; this page updates once verified.
How do I get a quote for Tramadol Hydrochloride/Etoricoxib intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-21